171 related articles for article (PubMed ID: 34045609)
21. IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.
Wang L; Bi XW; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ
Cancer Commun (Lond); 2018 Oct; 38(1):62. PubMed ID: 30340635
[TBL] [Abstract][Full Text] [Related]
22. p63 and p53 expression in extranodal NK/T cell lymphoma, nasal type.
Ye Z; Cao Q; Niu G; Liang Y; Liu Y; Jiang L; Yu X; Han A
J Clin Pathol; 2013 Aug; 66(8):676-80. PubMed ID: 23626008
[TBL] [Abstract][Full Text] [Related]
23. Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.
Li YQ; Luo CL; Jiang JX; He S; Liu Y; Yan WX; Xia Y; Cui Q; Huang Y; Lim JQ; Huang D; Hussein IN; Gao Y; Lin GW; Ling YH; Ma D; Zhang YT; Chan JY; Wei PP; Wang XX; Cheng CL; Xiong J; Zhao WL; Ong CK; Lim ST; Huang HQ; Peng RJ; Bei JX
Adv Sci (Weinh); 2023 Dec; 10(36):e2303913. PubMed ID: 37949673
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
Huang Y; de Reyniès A; de Leval L; Ghazi B; Martin-Garcia N; Travert M; Bosq J; Brière J; Petit B; Thomas E; Coppo P; Marafioti T; Emile JF; Delfau-Larue MH; Schmitt C; Gaulard P
Blood; 2010 Feb; 115(6):1226-37. PubMed ID: 19965620
[TBL] [Abstract][Full Text] [Related]
25. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
[TBL] [Abstract][Full Text] [Related]
26. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of IL-22, IL-23, and IL-17 for NK/T cell lymphoma.
Qi Y; Liao B; Chen J; Liang C; Chen Z; Xie B
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):150-155. PubMed ID: 37300674
[TBL] [Abstract][Full Text] [Related]
28. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
[No Abstract] [Full Text] [Related]
29. S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes.
Cheng P; Eksioglu EA; Chen X; Kandell W; Le Trinh T; Cen L; Qi J; Sallman DA; Zhang Y; Tu N; Adams WA; Zhang C; Liu J; Cleveland JL; List AF; Wei S
Leukemia; 2019 Aug; 33(8):2034-2046. PubMed ID: 30737486
[TBL] [Abstract][Full Text] [Related]
30. High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.
Wang H; Wang L; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Li ZM; Lu Y
Oncotarget; 2016 May; 7(22):33035-45. PubMed ID: 27105512
[TBL] [Abstract][Full Text] [Related]
31. Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
Qing M; Zhou T; Perova T; Abraham Y; Sweeney C; Krevvata M; Zhang X; Qi M; Gao G; Kim TM; Yao M; Cho SG; Eom HS; Lim ST; Yeh SP; Kwong YL; Yoon DH; Kim JS; Kim WS; Zhou L; Attar R; Verona RI
Ann Hematol; 2024 Jun; 103(6):1989-2001. PubMed ID: 38233570
[TBL] [Abstract][Full Text] [Related]
32. Predicting treatment response of patients with extranodal natural killer/T-cell lymphoma based on levels of PD-L1 mRNA and soluble PD-L1.
Feng Y; Jing C; Yu X; Cao X; Xu C
Hematol Oncol; 2020 Oct; 38(4):467-477. PubMed ID: 32515093
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
[TBL] [Abstract][Full Text] [Related]
34. The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma.
Zhang Z; Liu E; Zhang D; Zhao W; Wang G; Zhang Y; Huo Y; Zhang C; Li W
Diagn Pathol; 2023 Nov; 18(1):129. PubMed ID: 38037110
[TBL] [Abstract][Full Text] [Related]
35. TP73-AS1 promotes malignant progression of NK/T cell lymphoma by regulating DKK1 methylation.
Zhang H; Huang Q
J BUON; 2021; 26(4):1530-1535. PubMed ID: 34565015
[TBL] [Abstract][Full Text] [Related]
36. Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma.
Qi F; Wei Y; Wu M; Sun Y; Xie Y; Lin N; Liu W; Wang W; Song Y; Zhu J
Ann Hematol; 2024 May; 103(5):1643-1653. PubMed ID: 38191717
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
de Mel S; Hue SS; Jeyasekharan AD; Chng WJ; Ng SB
J Hematol Oncol; 2019 Apr; 12(1):33. PubMed ID: 30935402
[TBL] [Abstract][Full Text] [Related]
38. Advances in multiple omics of natural-killer/T cell lymphoma.
Xiong J; Zhao WL
J Hematol Oncol; 2018 Dec; 11(1):134. PubMed ID: 30514323
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
40. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]